From Surf Wiki (app.surf) — the open knowledge base
Tifluadom
Pair of enantiomers
Pair of enantiomers
| Field | Value | |||||
|---|---|---|---|---|---|---|
| Verifiedfields | changed | |||||
| Watchedfields | changed | |||||
| verifiedrevid | 461743259 | |||||
| image | Tifluadom.svg | |||||
| width | 215px | |||||
| image_class | skin-invert-image | |||||
| routes_of_administration | unknown | |||||
| CAS_number_Ref | ||||||
| CAS_number | 83386-35-0 | |||||
| ATC_prefix | none | |||||
| PubChem | 115208 | |||||
| IUPHAR_ligand | 1667 | |||||
| ChemSpiderID_Ref | ||||||
| ChemSpiderID | 103084 | |||||
| UNII_Ref | ||||||
| UNII | TF8X866L0I | |||||
| KEGG_Ref | ||||||
| KEGG | D02694 | |||||
| ChEMBL_Ref | ||||||
| ChEMBL | 169703 | |||||
| IUPAC_name | *N*-[[5-(2-Fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]thiophene-3-carboxamide | |||||
| C | 22 | H=20 | F=1 | N=3 | O=1 | S=1 |
| smiles | O=C(NCC1N(c3ccccc3C(=N/C1)\c2ccccc2F)C)c4ccsc4 | |||||
| StdInChI_Ref | ||||||
| StdInChI | 1S/C22H20FN3OS/c1-26-16(13-25-22(27)15-10-11-28-14-15)12-24-21(17-6-2-4-8-19(17)23)18-7-3-5-9-20(18)26/h2-11,14,16H,12-13H2,1H3,(H,25,27) | |||||
| StdInChIKey_Ref | ||||||
| StdInChIKey | NPGABYHTDVGGJK-UHFFFAOYSA-N |
| elimination_half-life =
Tifluadom is a benzodiazepine derivative with an unusual activity profile. Unlike most benzodiazepines, tifluadom has no activity at the GABAA receptor, but instead is a selective agonist for the κ-opioid receptor. It has potent analgesic and diuretic effects in animals, and also has sedative effects and stimulates appetite.
While tifluadom has several effects which might have potential uses in medicine, such as analgesia and appetite stimulation, κ-opioid agonists tend to produce undesirable effects in humans such as dysphoria and hallucinations, and so these drugs tend to only be used in scientific research. Dysphoric effects are similar to those seen when using other κ-opioid receptor agonists like pentazocine and salvinorin A, and can be considered the opposite of morphine-induced euphoria. As such, kappa agonists are believed to have very limited abuse potential.
References
References
- "2-Acylaminomethyl-1,4-benzodiazepine derivatives and their salts and pharmaceutical compositions thereof".
- (1982). "Unexpected opioid activity in a known class of drug". Life Sciences.
- (November 1986). "Tifluadom's effects under electric shock titration and tail-immersion procedures in squirrel monkeys". Life Sciences.
- (March 1984). "Kappa opioid agonists and antagonists: effects on drinking and urinary output". Appetite.
- (October 1984). "The role of opioid receptor sub-types in tifluadom-induced feeding". The Journal of Pharmacy and Pharmacology.
- (August 1987). "Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects.". Journal of Pharmacology and Experimental Therapeutics.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Tifluadom — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report